XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/marketdata/feature-july-stories-immunocore-genentech-immtacs-artes-bio-farma-vaccine/20%Daily2013-07-31 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsboehringer-eli-lilly-begin-enrolment-carmelina-study-diabetes-drug/20%Daily2013-07-31 17:30
https://www.clinicaltrialsarena.com/uncategorized/newskaryopharm-begins-phase-ib-trial-selinexor-advanced-sarcomas/20%Daily2013-07-31 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsastellas-fibrogen-commence-phase-ii-study-asp1517fg-4592-japan/20%Daily2013-07-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnektar-completes-enrolment-in-phase-iii-beacon-study-of-breast-cancer-drug/20%Daily2013-07-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsastars-gis-researchers-discover-potential-breast-cancer-drug-target/20%Daily2013-07-30 04:05
https://www.clinicaltrialsarena.com/uncategorized/newstakeda-unblinds-elm-pc-5-phase-iii-study-of-orteronel-for-prostate-cancer/20%Daily2013-07-28 17:30
https://www.clinicaltrialsarena.com/uncategorized/newshealth-decisions-completes-enrolment-in-amphora-non-hormonal-contraceptive-gel-study/20%Daily2013-07-25 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscuris-begins-phase-i-dose-escalation-study-of-cudc-427-advanced-malignancies/20%Daily2013-07-25 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstesaro-begins-patient-enrolment-phase-iii-trial-ovarian-cancer-agent/20%Daily2013-07-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnoxxon-pharma-completes-recruitment-for-phase-iia-diabetic-nephropathy-study/20%Daily2013-07-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspulmatrix-commences-phase-ib-study-of-chronic-obstructive-pulmonary-disease-agent/20%Daily2013-07-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsarray-biopharma-reports-positive-results-phase-ii-trial-asthma-drug/20%Daily2013-07-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsoncosec-reports-positive-interim-immune-response-data-from-phase-ii-study-of-immunopulse/20%Daily2013-07-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsrockwell-completes-dosing-in-second-phase-iii-study-of-soluble-ferric-pyrophosphate/20%Daily2013-07-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscubist-begins-enrolment-in-phase-iii-efficacy-studies-of-bevenopran/20%Daily2013-07-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscelsion-zhejiang-sign-memorandum-of-understanding-thermodox-development/20%Daily2013-07-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsalkermes-starts-phase-ii-study-of-schizophrenia-drug-candidate/20%Daily2013-07-18 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscelgene-terminate-phase-iii-origin-trial-revlimid/20%Daily2013-07-18 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsseattle-genetics-begins-sgn-cd33a-phase-i-trial-for-acute-myeloid-leukaemia/20%Daily2013-07-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssynergy-reaches-halfway-point-in-enrolment-of-plecanatide-phase-iib-trial/20%Daily2013-07-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsartes-bio-farma-to-jointly-develop-vaccine-candidates/20%Daily2013-07-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsamgen-reports-interim-safety-efficacy-results-phase-ii-trial-of-xgeva/20%Daily2013-07-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscelgenes-phase-iii-study-of-oral-revlimid-meets-primary-endpoint/20%Daily2013-07-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsrxi-reports-positive-data-from-second-phase-i-multi-dose-study-of-rxi-109/20%Daily2013-07-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsipsen-reports-positive-results-from-phase-iii-clarinet-study-of-somatuline-autogel/20%Daily2013-07-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsdaiichi-sankyo-reports-prasugrel-phase-iii-prasfit-elective-study-results/20%Daily2013-07-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newslorus-reports-positive-results-from-phase-i-trial-of-lor-253-anticancer-agent/20%Daily2013-07-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsohr-reaches-halfway-point-in-enrolment-of-squalamine-eye-drop-study/20%Daily2013-07-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsconvergence-begins-cnv2197944-phase-ii-study-to-treat-diabetic-peripheral-neuropathic-pain/20%Daily2013-07-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbellicum-starts-phase-i-trial-of-bpx-201-ap1903-for-metastatic-castrate-resistant-prostate-cancer/20%Daily2013-07-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsdbv-completes-enrolment-in-viaskin-peanut-phase-iib-clinical-trial/20%Daily2013-07-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnovavax-begins-phase-i-trial-of-vlp-based-vaccine-candidate-for-ah7n9-influenza/20%Daily2013-07-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsablynx-begins-additional-phase-i-trials-with-alx-0171-anti-respiratory-syncytial-virus-nanobody/20%Daily2013-07-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnovartis-lucentis-gets-eu-approval-to-treat-pathologic-myopia/20%Daily2013-07-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsultragenyx-reports-positive-interim-data-phase-ii-study-oral-sialic-acid-tablet/20%Daily2013-07-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsk-begins-phase-iii-study-subcutaneous-ofatumumab-treat-pemphigus-vulgaris/20%Daily2013-07-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsventirx-begins-active8-phase-ii-trial-of-vtx-2337/20%Daily2013-07-03 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspergamums-ll-37-demonstrates-efficacy-in-phase-iii-study-for-venous-leg-ulcer-treatment/20%Daily2013-07-03 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgalapagos-commences-phase-i-study-of-glpg1205-for-inflammatory-disorders/20%Daily2013-07-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscsl-behring-reports-results-pharmacokinetic-study-rviii-singlechain-hemophilia-a/20%Daily2013-07-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsimmunocore-genentech-collaborate-to-develop-immtacs-against-multiple-cancers/20%Daily2013-07-01 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsneurocrine-completes-recruitment-in-phase-iib-kinect-study-of-tardive-dyskinesia-drug/20%Daily2013-07-01 17:30